Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer

S. Jang (Anyang, Republic of Korea), S. Park (Dongtan, Republic of Korea), C. Lee (Chuncheon, Republic of Korea), J. Park (Anyang, Republic of Korea), J. Kim (Anyang, Republic of Korea), S. Park (Anyang, Republic of Korea), Y. Hwang (Anyang, Republic of Korea), K. Jung (Anyang, Republic of Korea)

Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2224
Disease area: Thoracic oncology

Congress or journal article abstractWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Jang (Anyang, Republic of Korea), S. Park (Dongtan, Republic of Korea), C. Lee (Chuncheon, Republic of Korea), J. Park (Anyang, Republic of Korea), J. Kim (Anyang, Republic of Korea), S. Park (Anyang, Republic of Korea), Y. Hwang (Anyang, Republic of Korea), K. Jung (Anyang, Republic of Korea). Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer. 2224

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: